SCHEMBL3852540

SCHEMBL3852540

CSc1ccc(-c2n[nH]cc2-c2ccc3ncnc(-c4ccc(S(C)(=O)=O)s4)c3c2)cc1

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
STK17B O94768 1/20 0.33
MAP3K8 P41279 1/20 0.33
STK17A Q9UEE5 1/20 0.33
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
LMNA P02545 1/20 0.32
PTGS2 P35354 1/20 0.31
KIT P10721 2/20 0.31
PIK3CD O00329 1/20 0.30
PIK3CA P42336 1/20 0.30
PIK3CB P42338 1/20 0.30
MTOR P42345 1/20 0.30
PIK3CG P48736 1/20 0.30
MAP4K4 O95819 1/20 0.30
CD38 P28907 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3854332 0.91 KIT (0.35) CA12CA1CA2CA9KIT
SCHEMBL4715276 0.90 KIT (0.38) LMNAPTGS2KITPIK3CAMTOR
Hydrochloric Acid SCHEMBL3854735 0.89 KIT (0.38) LMNAPTGS2KITPIK3CAMTOR
Hydrochloric Acid SCHEMBL3846886 0.89 MAP4K4 (0.34) MAP3K8CA12CA1CA2CA9
Hydrochloric Acid SCHEMBL3851460 0.88 MAP4K4 (0.38) LMNAKITMAP4K4
SCHEMBL3848264 0.88 CYP1A2 (0.39) LMNAPIK3CDPIK3CAPIK3CBMTOR
SCHEMBL3848218 0.88 KIT (0.36) LMNAKITCD38
SCHEMBL3847588 0.87 KIT (0.35) STK17BCA12CA1CA2CA9
SCHEMBL3848216 0.87 CA12 (0.34) CA12CA1CA2CA9LMNA
Hydrochloric Acid SCHEMBL5853419 0.86 MAP4K4 (0.37) STK17BMAP3K8LMNAKITPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed